Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05658653 · ClinicalTrials.gov registry record · NA
Clinical Utility of CDMT Among VillageMD Providers
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT05658653: Completed NA study, sponsored by Qure Healthcare.
NCT05658653 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05658653, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
This is a health system-level research study of physicians and care providers. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling, and other) of a subset of common patient care indications.
Primary Outcome
Using the responses to the simulated patient cases to measure the baseline levels of variation in the work-up, recognition, and management of medication non-adherence and/or DDI in patients with more than one cardiometabolic condition and associated polypharmacy. Work-up, recognition, and management scores will be combined to report variation in total assessment of the simulated patient cases.
Interventions
- OTHER Educational Materials for Chronic Disease Management Test (CDMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2022-08-16 |
| Est. Completion | 2023-01-10 |
| Phase | NA |
What the finished NCT05658653 record still lists
NCT05658653 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Educational Materials for Chronic Disease Management Test (CDMT) is the first listed.
NCT05658653 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05658653 about?
NCT05658653 is a clinical study titled "Clinical Utility of CDMT Among VillageMD Providers". This is a health system-level research study of physicians and care providers. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling, and other) of a subset of common patient care indications.
What is the current status of trial NCT05658653?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2022-08-16. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT05658653?
The interventions under investigation include: Educational Materials for Chronic Disease Management Test (CDMT) (OTHER).
Who is sponsoring clinical trial NCT05658653?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05658653's enrollment target sits among peer trials
166 625th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI